Media strategy powerhouse CMI Media Group, a WPP company (NYSE: WPP), announced marked success in growth and efficiencies within its Analytics and Insights unit. As part of an overall agency initiative to improve all aspects of business to continue a multi-year strong trajectory of growth, the department recognized 28 employees with promotions and collaborated across the agency to identify new opportunities to be efficient and provide even better outcomes for clients. This includes diving deeper into utilizing machine learning for more effective marketing outcomes. One elevation of note is that of Selamawit Gilagaber to Executive Vice President, Customer Insights.
If you are not happy with the results below please do another search
50 search results for:
The number of births in the United States grew 1% in 2021 from a pandemic low in 2020, marking the first increase since 2014, according to a report by the U.S. Centers for Disease Control and Prevention (CDC).
The Federal Trade Commission said on Tuesday it has launched an inquiry into the ongoing shortage for infant formula.
Ogilvy Health today announced industry veteran Courtney Murphy has been appointed to the position of Global People Director, a newly created role that now rounds out the agency’s powerhouse leadership team. Courtney will serve both as a valued part of the Ogilvy Health Executive Leadership Team and as a board member on Ogilvy’s Global People Team.
The American Society of Clinical Oncology (ASCO) and the Association of Community Cancer Centers (ACCC) are combining their efforts to increase racial and ethnic diversity in clinical trials.
After announcing plans to explore strategic alternatives less than a month ago, Genocea Biosciences is shutting down operations.
Patients who experience recurrence of COVID-19 symptoms after completing treatment with Pfizer’s drug Paxlovid should isolate again for five days, the U.S. Centers for Disease Control and Prevention said in an advisory issued on Tuesday.
Imugene and City of Hope announced this week that the first patient has begun treatment in a revolutionary Phase I clinical trial, investigating the safety and efficacy of CF33-hNIS (Vaxinia), a cancer-killing virus, in adults with metastatic or advanced tumors.
Moderna Inc. is testing potential vaccines against monkeypox in preclinical trials as the disease spreads in the United States and Europe.
A global health fund has raised a third of the $18 billion it says is needed to reverse setbacks caused by the coronavirus pandemic and combat AIDS, malaria, and tuberculosis.